SAVILLS PLC (THE "COMPANY")
Vesting of Share Awards
Awards over ordinary shares of the Company under the Deferred Share Plan have become unconditional in all respects following the end of their Deferred Period. In satisfaction of the Awards, the Trustee of the Savills US Employee Benefit Trust effected the transfer of shares to a PDMR of the Company based in North America on 19 June 2026 as follows:-
|
PDMR |
Number of Shares Transferred |
Shareholding following this notification |
Shareholding as a % of issued share capital |
|
David Lipson |
37,974 |
213,734 |
0.15%
|
The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.
|
1. |
Details of the Director/ PDMR
|
||
|
(a) |
Name |
David Lipson
|
|
|
2. |
Reason for the notification
|
||
|
(a) |
Position/ status |
Chief Executive Officer - Savills North America/ PDMR
|
|
|
(b) |
Initial notification/ Amendment
|
Initial notification |
|
|
3. |
Details of the issuer
|
||
|
(a) |
Name |
Savills plc
|
|
|
(b) |
LEI |
213800WXICGMBWHTA933
|
|
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
||
|
(a) |
Description of the Financial Instrument
|
Savills plc Ordinary Shares of 2.5p each |
|
|
(b) |
Identification code of the Financial Instrument
|
GB00B135BJ46 |
|
|
(c) |
Nature of the transaction
|
Vesting of awards under the Company's Deferred Share Plan
|
|
|
(d) |
Price(s) and volume(s)
|
Price(s) |
Volume(s)
|
|
£nil per share
|
37,974 |
||
|
(e) |
Aggregated information
- Aggregated volume - Price
|
N/A
|
|
|
(f) |
Date of the transaction
|
19 June 2026 |
|
|
(g) |
Place of the transaction
|
Outside a trading venue
|
|
Name of contact and telephone number for queries:
Chris Lee
Group Legal Director & Company Secretary
020 3107 5444
19 June 2026